Defendant

Mylan Inc.

2 cases as defendant.

Cases
2
Active
0
2 closed
Filed
2019
Top venue
D. Delaware
1 case

Merck Sharp & Dohme LLC v. Mylan Pharmaceuticals Inc. et al.

judgment; on appeal
Docket:
1:19-cv-00101-IMK
Filed:
2019-05-02
Patents:7326708

Merits action asserting '708 claim 3 for infringement and challenging claims 1, 2, 3, and 19 for validity. After a five-day bench trial, the court found Mylan's ANDA products infringe claim 3 (Doc. 204, Oct. 26, 2022); Mylan appealed.